Is the Wolverine Stack Still Banned? WADA and USADA Status Update 2025

The “Wolverine Stack” is a powerful, non-traditional collection of synthetic compounds encompassing Selective Androgen Receptor Modulators (SARMs) and advanced regenerative peptides (like BPC-157 and TB-500). It is highly sought after for its potential to accelerate healing, enhance muscle growth, and improve recovery.

The stack is named for its supposed ability to confer superhuman healing and resilience. However, for any athlete subject to the rules of the World Anti-Doping Agency (WADA) or the U.S. Anti-Doping Agency (USADA), the use of these agents represents an immediate and catastrophic threat to their career.

The definitive status for 2025 and 2026 is unambiguous. Every core component of the Wolverine Peptide Stack is strictly prohibited at all times for all athletes under the World Anti-Doping Code (the Code).

This prohibition is not a complex, evolving matter. Rather, it’s a clear enforcement of three fundamental categories on the WADA Prohibited List. This comprehensive analysis will detail the specific WADA classifications, the scientific rationale for the bans based on performance enhancement and severe health risks, the sophisticated detection methods used. It will also delve into the real-world, career-ending sanctions handed down by USADA for their use.

Table of Contents

The Unwavering Prohibition: WADA Categories S1, S2, and S0

New here? Wolverine Peptide Stack overview | Legal status by country (USA/UK/AU/CA)

The WADA Prohibited List (the List) operates on a principle that is both specific and broadly inclusive. It ensures that as new performance-enhancing substances emerge, they are automatically captured. The Wolverine Stack is banned across three critical, overlapping sections of the List. They apply both In-Competition and Out-of-Competition.

Category S1: Anabolic Agents (SARMs), The Direct Muscle Enhancers

This category bans substances that promote muscle mass and strength. It primarily encompasses steroids and their synthetic analogs.

SARMs (Selective Androgen Receptor Modulators): Compounds such as Ostarine (MK-2866), Ligandrol (LGD-4033), and Testolone (RAD-140) are explicitly listed as Prohibited Substances under Category S1.2, “Other Anabolic Agents” [1].
Scientific Mechanism of Action: SARMs operate by acting as partial or full agonists on the androgen receptor (AR). Critically, they exhibit a high degree of tissue selectivity. They preferentially target the ARs in skeletal muscle and bone while minimizing binding affinity in prostatic and sebaceous tissues. This leads to potent, localized anabolic effects, stimulating muscle protein synthesis and promoting hypertrophy. It provides a direct, measurable advantage in strength-based and physique sports [2].
Rationale for Ban (Performance): The targeted and highly effective nature of SARM-induced anabolism is precisely why they are banned. Their mechanism of action bypasses the natural regulatory limits that the body imposes on endogenous testosterone. This allows for supra-physiological signaling that directly enhances sport performance [7].
Rationale for Ban (Health Risk): SARMs remain unapproved, investigational drugs with incomplete safety data. Known risks include acute liver failure, cardiovascular risks, and negative impacts on the lipid profile [2]. The gray-market supply chain compounds this risk through unknown impurities and adulteration.
2025–2026 Status: SARMs remain firmly prohibited. Their classification as Non-Specified Substances indicates WADA views their use as intentional doping. This triggers a default sanction of four years of ineligibility for a first offense [1, 4].

Category S2: Peptide Hormones and Mimetics (Growth Hormone Secretagogues) – The Systemic Enhancers

This category covers agents that systemically boost the body’s natural production of powerful growth and repair factors.

GH Secretagogues: Peptides such as CJC-1295, Ipamorelin, Sermorelin, and GHRP-6 are classified under S2. They function as Growth Hormone Releasing Hormones (GHRHs) and Growth Hormone Releasing Peptides (GHRPs).
Scientific Mechanism of Action: GHRHs (like CJC-1295) bind to the Growth Hormone-Releasing Hormone Receptor (GHRH-R) in the pituitary gland. They stimulate GH production. GHRPs (like Ipamorelin) act via the ghrelin receptor (GHS-R), stimulating GH release and suppressing somatostatin (the GH-inhibitory hormone). When stacked, these two mechanisms create a potent, synergistic pulse of GH release [3]. This elevated GH then drives increased systemic levels of Insulin-like Growth Factor 1 (IGF-1) from the liver.
Rationale for Ban (Performance): Elevated IGF-1 is the direct mediator of the anabolic effects. They help promote muscle hypertrophy, collagen synthesis, and rapid connective tissue repair. This enhances recovery speed and increases the anabolic capacity. Thus, they provide an unfair advantage over naturally regulated physiological limits [3, 7].
Rationale for Ban (Health Risk): The long-term safety of artificially manipulating the pulsatile release of GH remains a major concern. This particularly concerns the promotion of latent malignancies. Furthermore, because these are frequently obtained as injectable powders from the unregulated gray market, the risk of systemic infection from non-sterile, endotoxin-contaminated products is extremely high. They pose an acute life threat [5]. To avoid common pitfalls in handling and use, review Wolverine Peptide Stack Beginner Mistakes (& How to Avoid Them).
2025–2026 Status: These GH-stimulating peptides remain Non-Specified Substances under S2. Their use results in the default four-year ban for a positive test [1, 4].

Category S0: Non-Approved Substances (Experimental Peptides) – The Catch-All Ban

This category is the most powerful tool WADA possesses for banning the experimental, gray-market compounds that constitute the rest of the Wolverine Stack.

The Explicit Inclusion of BPC-157: The highly publicized tissue repair peptide BPC-157 is explicitly listed as a prohibited substance and falls under the S0 category [5]. It was added following its emergence in the supplement market and its known ability to enhance healing and tissue strength through mechanisms that stimulate blood vessel formation and collagen production [5, 6].
TB-500 (Thymosin Beta 4 fragment): This peptide acts as a powerful cell repair and migration factor. It primarily promotes healing of the cardiovascular and musculoskeletal systems. It, too, falls under the S0 designation. This is due to its lack of any current governmental regulatory health authority approval for human therapeutic use [5].
Catch-All Definition: The fundamental rule of S0 is that it prohibits any pharmacological substance which is not included in any subsequent section of the List, and which has no current approval by any governmental regulatory health authority (e.g., FDA, EMA) for human therapeutic use [1].
Rationale for Ban (Health Risk and Integrity): This ban is critical for athlete protection. WADA prohibits S0 substances because their toxicity profile is unknown. Additionally, their required dosage is not clinically validated, and their purity is highly suspect when sourced from the unregulated market [7]. USADA states there is no TUE available for these compounds because they lack the necessary regulatory safety documentation [5].

Deep dive on the banned peptides: BPC-157: mechanisms & research | TB-500 explained (role in repair)

Detection and Testing Methods: WADA’s Advanced Analytics

The detection of the Wolverine Stack components, which are often peptides or small molecules, requires highly sophisticated analytical methods. Athletes must understand that WADA-accredited laboratories are consistently adapting their testing methodologies to ensure these banned substances are found.

Mass Spectrometry (MS): The primary detection method is Liquid Chromatography-Mass Spectrometry (LC-MS/MS). This provides the necessary sensitivity and specificity to identify these compounds in urine and blood samples. For peptides (S2 and S0), MS is crucial for confirming the molecular structure and differentiating the administered synthetic peptide from any naturally occurring analog [8].
Detection of SARMs (S1): SARMs are synthetic small molecules. Laboratories have developed highly sensitive analytical methods to detect not only the parent SARM compound but also the breakdown products created by the body [8]. This allows for a much longer window of detection, often weeks after the last dose. This is true even when the parent compound is no longer detectable.
Bio-Markers (The Athlete Biological Passport – ABP): While direct detection of GH-peptides (S2) is challenging due to their short half-lives, WADA uses the Endocrine Module of the Athlete Biological Passport (ABP). This involves monitoring longitudinal changes in biological markers (e.g., IGF-1, P-III-NP) that are indirectly affected by the use of GH secretagogues [8]. A significant shift in these biomarkers provides a strong presumptive case for doping, even without a direct positive test. WADA continuously updates the scientific rationale for these detection methods [6]. For a summary of the latest studies supporting these concerns, check out our Complete Research Summary: Published Studies on BPC-157 & TB-500 (2026 Update).

Strict Liability and Career-Ending Sanctions: USADA Enforcement

If you’re competing: Wolverine Stack for athletes (performance + compliance realities)

The principle of strict liability is the core tenet of anti-doping. The athlete is personally responsible for any prohibited substance found in their system. This is regardless of intent or how it got there. The USADA sanction list provides irrefutable evidence of the consequences for Wolverine Stack use.

Case Example 1: Composite Violation and the Four-Year Ban

The case of triathlon athlete Anthony McCauley, sanctioned in 2025, serves as the definitive example of the severity of using the composite Wolverine Stack:

The Violation: McCauley was sanctioned for the possession and use of a multiple-compound stack, including BPC-157 (S0), TB-500 (S0/S2), CJC-1295, and Ipamorelin (S2) [9]. The USADA investigation was triggered by whistleblower information and confirmed use of the prohibited agents.
The Consequence: Because the violation involved multiple Non-Specified Substances (CJC-1295 and Ipamorelin), the athlete accepted a four-year period of ineligibility, which is the default severe sanction [9]. Additionally, all competitive results obtained on and after the date the athlete began using the substances were disqualified and forfeited. This included medals, points, and prizes [9].
Legal Rationale: This case proves that using multiple Wolverine Stack components results in a single, aggregated Anti-Doping Rule Violation (ADRV) based on the most serious compound used. The severity reflects the intentional use of a systemic performance-enhancing program.

Case Example 2: The Ostarine Contamination Trap

Many athletes are sanctioned not for intentionally injecting peptides, but for unwittingly consuming SARMs in tainted supplements.

The Mechanism: Gray-market vendors intentionally “spike” or cross-contaminate muscle-building supplements with cheap, effective SARMs like Ostarine. This ensures consumers feel a noticeable effect and repurchase the product [8]. The athlete is often unaware the substance is present.
The Defense Failure: An athlete who tests positive for Ostarine after taking a contaminated supplement must attempt to prove “no significant fault or negligence” to reduce the ban [4]. This defense is almost impossible to mount successfully when dealing with black-market, unapproved drugs. This is because the athlete is seen as responsible for their choice of supplement. Even when contamination is acknowledged, the sanction often remains lengthy (often reduced to two years). This is due to the severe nature of the S1 substance.

The Uninsurable Cost: Financial and Ethical Consequences

The penalty for using the Wolverine Stack extends far beyond the competitive ban. The financial and ethical fallout is often career-ending.

Financial Ruin

Loss of Earnings: A four-year ban means the loss of all competitive earnings, salaries, and potential endorsement deals for the duration of the suspension. For high-level professional athletes, this represents millions of dollars in lost income.
Disgorgement of Prize Money: Under the Code, the athlete is required to repay any prize money earned from the date the violation occurred [9]. This can result in significant debt and financial hardship.
Legal Fees: Successfully defending an ADRV, even if the contamination defense is pursued, requires extensive testing and legal representation. This often costs tens of thousands of dollars, which can be a massive financial burden regardless of the outcome.

Ethical and Reputational Damage

Irreversible Reputational Harm: The public nature of USADA sanctions, which include the athlete’s name, sport, and the prohibited substances used, results in permanent reputational damage. This label affects future coaching opportunities, administrative roles, and media appearances long after the suspension ends.
Harm to the Sport: Every doping violation undermines the public trust in clean competition and the integrity of the athlete’s sport, violating the core principle of fair play [7].

Conclusion and Outlook 2025–2026

The Wolverine Stack is not only prohibited. It is actively targeted by anti-doping organizations with cutting-edge detection technologies. For 2025–2026, the ban remains total and absolute. The price of using the Wolverine Stack for a competitive athlete is the guaranteed loss of their career through a multi-year ban.

S1 & S2: Prohibit the muscle-building SARMs (Ostarine) and the systemic growth factors (Ipamorelin, CJC-1295)
S0: Prohibits the tissue-repair agents (BPC-157, TB-500) based on their unapproved status and unknown health risks. To understand the underlying synergy and mechanisms driving these risks, explore How the Wolverine Stack Works: Mechanisms of BPC-157 & TB-500 Synergy.

Any athlete who attempts to use these regenerative agents is knowingly violating the Code and risking sanctions that permanently disqualify all past and future competitive results. This is regardless of how subtle or “experimental” the compound is labeled.

For reliable sources if considering research use, see our Wolverine Peptide for Sale: 3 Most Reputable Sources.

Citations

[1] WADA Prohibited List (International Standard). https://www.wada-ama.org/sites/default/files/2024-09/2025list_en_final_clean_12_september_2024.pdf

[2] Selective Androgen Receptor Modulators (SARMs): Current knowledge and clinical applications. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941012/

[3] Growth hormone-releasing hormone (GHRH) and its synthetic analogs as novel anabolic agents. https://pubmed.ncbi.nlm.nih.gov/22197547/

[4] Sanctions – Anti-Doping Violations (U.S. Anti-Doping Agency – USADA). https://www.usada.org/results/sanctions/

[5] BPC-157: Experimental Peptide Creates Risk for Athletes – U.S. Anti-Doping Agency. https://www.usada.org/spirit-of-sport/bpc-157-peptide-prohibited/

[6] The 2025 revision of the World Anti-Doping Agency (WADA) Prohibited List: Implications for competitive sports. https://www.mdpi.com/2226-4787/11/5/154/

[7] Criteria for inclusion on the WADA Prohibited List. https://www.wada-ama.org/en/what-we-do/prohibited-list/criteria-for-inclusion

[8] Detection of Selective Androgen Receptor Modulators (SARMs) in sports drug testing. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216669/

[9] Triathlon Athlete Anthony McCauley Accepts Sanction for Anti-Doping Rule Violations (BPC-157; TB-500; CJC-1295; Ipamorelin). https://www.usada.org/sanction/anthony-mccauley-accepts-doping-sanction/

Is the Wolverine Stack Still Banned? WADA and USADA Status Update 2025–2026